CDK1 and cancer: The continuous activation of the NF-κB pathway can increase antiapoptotic gene Bcl-2 expression, upregulate expression of proliferation-related proteins CDK1 and CDK2, and promote cell cycle, thus promoting cancer cell proliferation.